|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61L 27/52 | (2006.01) |
| A61Q 19/08 | (2013.01) | ||
| A61K 8/735 | (2013.01) | ||
| A61K 8/042 | (2013.01) | ||
| A61K 8/24 | (2013.01) | ||
| A61K2800/80 | (2013.01) | ||
| A61L 27/52 | (2013.01) | ||
| A61L2400/06 | (2013.01) | ||
| A61L2430/34 | (2013.01) | ||
| A61L2430/40 | (2013.01) | ||
| A61L 27/46 | (2013.01) |
| (11) | Number of the document | 3509559 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17848293.1 |
| Date of filing the European patent application | 2017-09-07 | |
| (97) | Date of publication of the European application | 2019-07-17 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2017/051019 |
| Date | 2017-09-07 |
| (87) | Number | WO 2018/047182 |
| Date | 2018-03-15 |
| (30) | Number | Date | Country code |
| 201662384219 P | 2016-09-07 | US |
| (72) |
SEGAL, David Dadi , IL
GOLDBERG, Eran , IL
SHKLANOVSKY, Lital , IL
ZINGER, Ariel , IL
GOLDSHAID-ZMIRI, Liat , IL
|
| (73) |
Allergan Pharmaceuticals International Limited ,
Clonshaugh Business & Technology Park, Dublin 17, D17 E400,
IE
|
| (54) | METHODS OF MANUFACTURING INJECTABLE GELS COMPRISING CROSS-LINKED HYALURONIC ACID AND HYDROXYAPATITE |
| METHODS OF MANUFACTURING INJECTABLE GELS COMPRISING CROSS-LINKED HYALURONIC ACID AND HYDROXYAPATITE |